Paul D. Geenty

Hawkesbury Road
Westmead, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Monitoring of Treatment Response in Light-chain Cardiac Amyloidosis-Does Echocardiography Have a Role?

Monitoring of Treatment Response in Light-chain Cardiac Amyloidosis-Does Echocardiography Have a Role?

Journal: Echocardiography (Mount Kisco, N.Y.)

Published: April 25, 2026

Phenotyping the Many Faces of Hypertrophic Cardiomyopathy.

Phenotyping the Many Faces of Hypertrophic Cardiomyopathy.

Journal: Heart failure clinics

Published: October 13, 2025

99m Technetium-pyrophosphate SPECT/CT with novel semiautomated quantification has excellent diagnostic accuracy for detecting cardiac transthyretin amyloidosis.

99m Technetium-pyrophosphate SPECT/CT with novel semiautomated quantification has excellent diagnostic accuracy for detecting cardiac transthyretin amyloidosis.

Journal: Nuclear medicine communications

Published: March 12, 2025

Plot thickens: the progression of left ventricular 'hypertrophy' in Fabry disease.

Plot thickens: the progression of left ventricular 'hypertrophy' in Fabry disease.

Journal: Heart (British Cardiac Society)

Published: July 23, 2024

Atrial cardiomyopathy in cardiac amyloidosis: clinical imaging and manifestations.

Atrial cardiomyopathy in cardiac amyloidosis: clinical imaging and manifestations.

Journal: NPJ cardiovascular health

Published: July 01, 2024

Cardio-Oncology-Beyond Anthracyclines and Ejection Fraction.

Cardio-Oncology-Beyond Anthracyclines and Ejection Fraction.

Journal: Heart, lung & circulation

Published: June 01, 2024

Diagnostic and prognostic value of the left atrial myopathy evaluation in cardiac amyloidosis using echocardiography.

Diagnostic and prognostic value of the left atrial myopathy evaluation in cardiac amyloidosis using echocardiography.

Journal: ESC heart failure

Published: January 04, 2024

Transthyretin Cardiac Amyloidosis in Australia and New Zealand-A Multi-Site Snapshot for 2022.

Transthyretin Cardiac Amyloidosis in Australia and New Zealand-A Multi-Site Snapshot for 2022.

Journal: Heart, lung & circulation

Published: December 18, 2023

Pulmonary embolism response teams. A description of the first 36-month Australian experience.

Pulmonary embolism response teams. A description of the first 36-month Australian experience.

Journal: Internal medicine journal

Published: September 03, 2023

A novel echocardiographic risk score for light-chain amyloidosis.

A novel echocardiographic risk score for light-chain amyloidosis.

Journal: European heart journal open

Published: March 30, 2023

Cardiac "hypertrophy" phenotyping: differentiating aetiologies with increased left ventricular wall thickness on echocardiography.

Cardiac "hypertrophy" phenotyping: differentiating aetiologies with increased left ventricular wall thickness on echocardiography.

Journal: Frontiers in cardiovascular medicine

Published: March 10, 2023

Alterations in multi-layer strain in AL amyloidosis.

Alterations in multi-layer strain in AL amyloidosis.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: February 21, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026